Development of an MSK Imaging Biomarker, Insights From the QIBA Process

    Introduction

    Author:

    Session Type:Member-Initiated Symposium  

    Session Date:Monday, 09 May 2022  

    Topic:

    Session Name:From Basic Research to the End User: MR Biomarkers for Muscle & MSK Diseases  

    Program Number:

    Room Session:ICC Capital Hall 2  

    Institution:

      MR Imaging Biomarker for the Evaluation of Efficacy of Cartilage Repair Therapies

        Muscle Fat Fraction as an Outcome in Multicenter Clinical Trials for Muscular Dystrophy

          Perfusion MRI as Biomarker in Musculoskeletal Diseases

            Translational Imaging for the Assessment of Therapies for Musculo-Skeletal Indications: Part I

              Translational Imaging for the Assessment of Therapies for Musculo-Skeletal Indications: Part II